Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia remission is likely when lymphangiogenesis factor is absent
Published in Blood Weekly, September 14th, 2006
Scientists in Poland conducted a study "to investigate the immunocytochemical expression of vascular endothelial growth factor C (VEGF-C) and its receptors (VEGFR-2 and VEGFR-3) in childhood ALL blasts and to determine the possible role of this complex in the pathogenesis and prognosis of ALL. Bone marrow samples were taken from 120 children diagnosed with ALL."
"An indirect immunocytochemical procedure was performed with the use of monoclonal mouse anti-human antibodies against VEGF-C, VEGFR-2 and VEGFR-3 (diluted 1:100). The immunocytochemical expression...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-09-14)
More Articles from Blood Weekly
- Blood Banking
Flu pandemic may impact blood supply via reduced blood donations and blood center staffing - Tissue Engineering
Living autologous heart valves engineered from prenatally harvested progenitors - Tissue Engineering
Macroporous and nanofibrous poly(L-lactic acid) scaffold mimics natural bone matrix - Tissue Engineering
Proepicardium is a suitable cellular source for vascular tissue engineering - Acute Lymphoblastic Leukemia
Hana initiates Marqibo phase II trial in relapsed or refractory acute lymphoblastic leukemia - Acute Myeloid Leukemia
Acute myeloid leukemia is detected by angiogenesis biomarkers - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
